TY - JOUR
T1 - The Role of Comorbidities in Predicting Functional Improvement After Transcatheter Aortic Valve Implantation
AU - Gard, Emma K.
AU - Noaman, Samer
AU - Stub, Dion
AU - Vriesendorp, Pieter
AU - Htun, Nay
AU - Johnston, Rozanne
AU - Gartner, Elisha
AU - Dick, Ronald
AU - Walton, Antony
AU - Kaye, David
AU - Nanayakkara, Shane
N1 - Publisher Copyright:
© 2024
PY - 2024/7
Y1 - 2024/7
N2 - Background: Patients undergoing transcatheter aortic valve implantation (TAVI) have a high comorbidity burden. We sought to stratify patients into functional outcomes using the Kansas City Cardiomyopathy Questionnaire (KCCQ-12), a patient-reported outcome with benefits over both the New York Heart Association (NYHA) classification and the original 23-item KCCQ, and to evaluate the importance of comorbidities in predicting failure of functional improvement post-TAVI in a contemporary cohort. Methods: In total, 366 patients with severe aortic stenosis undergoing TAVI with baseline KCCQ-12 were retrospectively analysed and divided into two groups. Failure to improve was defined as a score <60 and a change in score <10 at 1 year in either overall score (KCCQ-OS) or clinical summary score (KCCQ-CSS). Results: Failure to improve was noted in 13% of patients, who were more likely to have lower KCCQ-OS at baseline (47 [35–59] vs 56 [42–74]), chronic obstructive pulmonary disease (COPD) (19% vs 8%), severe chronic kidney disease (CKD) (13% vs 2%), a clinical frailty score (CFS) ≥5 (41% vs 14%), and lower serum albumin (36 g/L [34–38] vs 38 g/L [35–40]). On multivariate analysis, with an area under the curve of 0.71 (0.63–0.78), baseline KCCQ-OS (adjusted odds ratio [aOR] 0.3 [0.1–0.6], p=0.04), COPD (aOR 2.8 [1.2–6.5], p=0.02), and severe CKD (aOR 5.7 [1.7–18.5], p=0.004) remained independent predictors. CFS alone had a similar predictive value as the multivariable model (OR 2.0 [1.3–3.4], area under the curve 0.69 [0.59–0.80], p<0.001). Conclusions: KCCQ scores were effective in delineating functional outcomes, with most patients in our relatively lower surgical risk cohort showing significant functional improvements post-TAVI. Low baseline KCCQ, moderate or worse COPD, and severe CKD were associated with failure of improvement post-TAVI. Baseline CFS appears to be a good screening tool to predict poor improvement. These factors should be evaluated and weighted accordingly in pre-TAVI assessments and decision-making.
AB - Background: Patients undergoing transcatheter aortic valve implantation (TAVI) have a high comorbidity burden. We sought to stratify patients into functional outcomes using the Kansas City Cardiomyopathy Questionnaire (KCCQ-12), a patient-reported outcome with benefits over both the New York Heart Association (NYHA) classification and the original 23-item KCCQ, and to evaluate the importance of comorbidities in predicting failure of functional improvement post-TAVI in a contemporary cohort. Methods: In total, 366 patients with severe aortic stenosis undergoing TAVI with baseline KCCQ-12 were retrospectively analysed and divided into two groups. Failure to improve was defined as a score <60 and a change in score <10 at 1 year in either overall score (KCCQ-OS) or clinical summary score (KCCQ-CSS). Results: Failure to improve was noted in 13% of patients, who were more likely to have lower KCCQ-OS at baseline (47 [35–59] vs 56 [42–74]), chronic obstructive pulmonary disease (COPD) (19% vs 8%), severe chronic kidney disease (CKD) (13% vs 2%), a clinical frailty score (CFS) ≥5 (41% vs 14%), and lower serum albumin (36 g/L [34–38] vs 38 g/L [35–40]). On multivariate analysis, with an area under the curve of 0.71 (0.63–0.78), baseline KCCQ-OS (adjusted odds ratio [aOR] 0.3 [0.1–0.6], p=0.04), COPD (aOR 2.8 [1.2–6.5], p=0.02), and severe CKD (aOR 5.7 [1.7–18.5], p=0.004) remained independent predictors. CFS alone had a similar predictive value as the multivariable model (OR 2.0 [1.3–3.4], area under the curve 0.69 [0.59–0.80], p<0.001). Conclusions: KCCQ scores were effective in delineating functional outcomes, with most patients in our relatively lower surgical risk cohort showing significant functional improvements post-TAVI. Low baseline KCCQ, moderate or worse COPD, and severe CKD were associated with failure of improvement post-TAVI. Baseline CFS appears to be a good screening tool to predict poor improvement. These factors should be evaluated and weighted accordingly in pre-TAVI assessments and decision-making.
KW - Frailty
KW - KCCQ
KW - Patient reported outcomes
KW - TAVI
UR - https://www.scopus.com/pages/publications/85189494802
U2 - 10.1016/j.hlc.2024.02.002
DO - 10.1016/j.hlc.2024.02.002
M3 - Article
C2 - 38582702
AN - SCOPUS:85189494802
SN - 1443-9506
VL - 33
SP - 1018
EP - 1026
JO - Heart Lung and Circulation
JF - Heart Lung and Circulation
IS - 7
ER -